NIH Launches $100 Million Pandemic Preparedness Research Network

Click to Enlarge

The National Institutes of Health (NIH) has launched the Research and Development of Vaccines and Monoclonal Antibodies for Pandemic Preparedness (ReVAMPP) network to tackle future pandemic threats. With a focus on “prototype pathogens,” the research aims to preemptively develop vaccines and antibodies for high-risk viruses, building on past success with COVID-19 vaccine research. Albert Einstein College of Medicine in New York City is one of several awardees, advancing pandemic preparedness with innovative scientific approaches.

NIH awards establish pandemic preparedness research network (NIH, 9/24).

Categories: All Categories, Featured News, Pulse 9/20/2024Published On: September 19th, 2024Tags: , ,

Share